A1BV4

N-(4-amino-1H-pyrazolo[4,3-c]pyridin-7-yl)-2-[(2R,5S)-2-(1,3-benzothiazol-5-yl)-5-methylpiperidin-1-yl]-2-oxoacetamide

Created:	2025-02-03
Last modified:	2025-03-12

Find Related PDB Entry
1 entries where A1BV4 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	2
Bond Count	56
Aromatic Bond Count	20

2D diagram of A1BV4

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-(4-amino-1H-pyrazolo[4,3-c]pyridin-7-yl)-2-[(2R,5S)-2-(1,3-benzothiazol-5-yl)-5-methylpiperidin-1-yl]-2-oxoacetamide
Systematic Name (OpenEye OEToolkits)	~{N}-(4-azanyl-1~{H}-pyrazolo[4,3-c]pyridin-7-yl)-2-[(2~{R},5~{S})-2-(1,3-benzothiazol-5-yl)-5-methyl-piperidin-1-yl]-2-oxidanylidene-ethanamide
Formula	C₂₁ H₂₁ N₇ O₂ S
Molecular Weight	435.502
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	Nc1ncc(NC(=O)C(=O)N2CC(C)CCC2c2cc3ncsc3cc2)c2[NH]ncc21
SMILES	CACTVS	3.385	C[CH]1CC[CH](N(C1)C(=O)C(=O)Nc2cnc(N)c3cn[nH]c23)c4ccc5scnc5c4
SMILES	OpenEye OEToolkits	3.1.0.0	CC1CCC(N(C1)C(=O)C(=O)Nc2cnc(c3c2[nH]nc3)N)c4ccc5c(c4)ncs5
Canonical SMILES	CACTVS	3.385	C[C@H]1CC[C@@H](N(C1)C(=O)C(=O)Nc2cnc(N)c3cn[nH]c23)c4ccc5scnc5c4
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	C[C@H]1CC[C@@H](N(C1)C(=O)C(=O)Nc2cnc(c3c2[nH]nc3)N)c4ccc5c(c4)ncs5
InChI	InChI	1.06	InChI=1S/C21H21N7O2S/c1-11-2-4-16(12-3-5-17-14(6-12)24-10-31-17)28(9-11)21(30)20(29)26-15-8-23-19(22)13-7-25-27-18(13)15/h3,5-8,10-11,16H,2,4,9H2,1H3,(H2,22,23)(H,25,27)(H,26,29)/t11-,16+/m0/s1
InChIKey	InChI	1.06	JVFAOCFMASFRKM-MEDUHNTESA-N

Related Resource References

Resource Name	Reference
PubChem	169114981

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.